|
Click to see investors that are a fit for your product and stage of development
|
|
Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you
|
|
Click here if you want to receive free, targeted early stage dealflow for your life science investment firm
|
|
|
 |
 |
Yesterday, we held the Redefining Early Stage Investments (RESI) conference in New York for the first time, and 36 finalists competed for "investment" tokens from the RESI audience. These finalists included companies developing novel drugs or devices, new diagnostics and healthcare IT applications. All of these companies have the potential to revolutionize medicine, but there could only be 3 top prize winners.
First Place: Sen-Jam Pharma
|
|
| Jim Iversen, CEO & COO, Sen-Jam Pharmaceutical | Natasha Eldridge, Director of RESI Conference Series, LSN | Thomas Dahl, Head of Product Development, Regulatory Affairs, Sen-Jam Pharmaceutical | Lucy Parkinson, Director of Investor Research, LSN |
Second Place: Bioharmony Therapeutics
|
|
| Chandrabali Ghose, Founder & CEO, Bioharmony Therapeutics | Natasha Eldridge, Director of RESI Conference Series, LSN | Lucy Parkinson, Director of Investor Research, LSN |
Third Place: Mirimus
|
|
| Prem Premsrirut, Founder & CEO, Mirimus | Lucy Parkinson, Director of Investor Research, LSN | Natasha Eldridge, Director of RESI Conference Series, LSN |
If you missed out on the opportunity to compete in the RESI NYC Innovation Challenge, we'd be happy to take your application for our upcoming San Francisco event on January 9th.
RESI San Francisco Innovation Challenge, Jan. 9, 2018
|
|
|
|
QuickFire Challenge
I
n honor of the Grand Opening of JLABS @ NYC, Johnson & Johnson Innovation has launched a QuickFire Challenge to award up to four new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ NYC community for one year.
|
This competition will award the person or team(s) who submits the best idea, technology, or solution in the following areas:
- Consumer healthcare
- Health technologies
- Medical devices
- Therapeutics
|
 |
|
|
|
